Loss of heterozygosity on chromosome arm 11q in lung carcinoids

被引:38
|
作者
Petzmann, S
Ullmann, R
Klemen, H
Renner, H
Popper, HH
机构
[1] Graz Univ, Sch Med, Inst Pathol, Lab Environm & Resp Pathol, A-8036 Graz, Austria
[2] Graz Univ, Sch Med, Dept Thorac & Hyperbar Surg, A-8036 Graz, Austria
关键词
neuroendocrine lung tumors; lung carcinoid; loss of heterozygosity on chromosome 11q; genetic alterations;
D O I
10.1053/hupa.2001.22762
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Neuroendocrine lung tumors such as typical carcinoid, atypical carcinoid, small-fell lung carcinoma, and large-cell neuroendocrine carcinoma represent a variable group with different biologic characteristics and unclear genetical relationships. We investigated the pattern of allelic loss on chromosome arm 11q in 20 sporadic carcinoid tumors of the lung using 10 microsatellite markers. Loss of heterozygosity was found in 13 of 20 tumors. In 5 of 9 typical carcinoids, 3 distinct regions of allelic loss were identified: 11q13.1 (D11S1883), 11q14.3-11q21(D11S906), and 11q25 (D11S910). Atypical carcinoids showed loss of heterozygosity at 4 different regions: the first, most proximal region at 11q13 between markers PYGM and D11S937; the second at 11q14.3-11q21 (D11S906); and the third and fourth defined by markers D11S939 (11q23.2-23.3) and D11S910 (11q25). However, the region 11q13 harboring the MEN1 gene was more frequently affected in atypical carcinoids (7 of 11) than in typical carcinoids (2 of 9). The high rate of allelic losses within chromosomal region 11q13 in atypical carcinoids emphasizes the importance of this region for tumor development. We also recognized that more aggressive atypical carcinoids defined by high mitotic counts, vascular invasion, and/or organ metastasis are combined with increased allelic losses. HUM PATHOL 32:333-338. Copyright (C) 2001 by W.B. Saunders Company.
引用
收藏
页码:333 / 338
页数:6
相关论文
共 50 条
  • [1] LOSS OF HETEROZYGOSITY ON CHROMOSOME 11Q IN BREAST-CANCER
    TOMLINSON, IPM
    STICKLAND, JE
    LEE, ASG
    BROMLEY, L
    EVANS, MF
    MORTON, J
    MCGEE, JO
    JOURNAL OF CLINICAL PATHOLOGY, 1995, 48 (05) : 424 - 428
  • [2] Definition of a region of loss of heterozygosity at chromosome 11q in cervical carcinoma
    Mugica-Van Herckenrode, C
    Rodriguez, JA
    Iriarte-Campo, V
    Carracedo, A
    Barros, F
    DIAGNOSTIC MOLECULAR PATHOLOGY, 1999, 8 (02) : 92 - 96
  • [3] Tee frequency and mechanism of loss of heterozygosity on chromosome 11q in breast cancer
    Tomlinson, IPM
    Nicolai, H
    Solomon, E
    Bodmer, WF
    JOURNAL OF PATHOLOGY, 1996, 180 (01): : 38 - 43
  • [4] Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer
    Davis, M
    Hitchcock, A
    Foulkes, WD
    Campbell, IG
    CANCER RESEARCH, 1996, 56 (04) : 741 - 744
  • [5] Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma
    Hui, ABY
    Lo, KW
    Leung, SF
    Choi, PHK
    Fong, Y
    Lee, JCK
    Huang, DP
    CANCER RESEARCH, 1996, 56 (14) : 3225 - 3229
  • [6] Frequent loss of chromosome 11q and 22q loci in insulinomas
    Jonkers, Y
    Claessen, S
    Feuth, T
    van Kessel, G
    Ramaekers, F
    Veltman, JAA
    Speel, EJM
    NEUROENDOCRINOLOGY, 2006, 83 (01) : 58 - 58
  • [7] LOSS OF HETEROZYGOSITY AT CHROMOSOME-11Q IN LUNG ADENOCARCINOMA - IDENTIFICATION OF 3 INDEPENDENT REGIONS
    RASIO, D
    NEGRINI, M
    MANENTI, G
    DRAGANI, TA
    CROCE, CM
    CANCER RESEARCH, 1995, 55 (18) : 3988 - 3991
  • [8] LOSS OF HETEROZYGOSITY ON THE LONG ARM OF CHROMOSOME-11 IN COLORECTAL TUMORS
    GUSTAFSON, CE
    YOUNG, J
    LEGGETT, B
    SEARLE, J
    CHENEVIXTRENCH, G
    BRITISH JOURNAL OF CANCER, 1994, 70 (03) : 395 - 397
  • [9] Allele loss on chromosome 11q and microsatellite instability in malignant melanoma
    Tomlinson, IPM
    Beck, NE
    Bodmer, WF
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (10) : 1797 - 1802
  • [10] Mutations/deletions of the WT1 gene, loss of heterozygosity on chromosome arms 11p and 11q, chromosome ploidy and histology in Wilms' tumors in Japan
    Nakadate, H
    Yokomori, K
    Watanabe, N
    Tsuchiya, T
    Namiki, T
    Kobayshi, H
    Suita, S
    Tsunematsu, Y
    Horikoshi, Y
    Hatae, Y
    Endo, M
    Komada, Y
    Eguchi, H
    Toyoda, Y
    Kikuta, A
    Kobayashi, R
    Kaneko, Y
    INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (03) : 396 - 400